rfhg_166619.1

Basic information about the TSS

---

TSS ID: rfhg_166619.1 Species: human Chr: chr14		Start: 60092097 End: 60092114 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2725048,EH38E1718602)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000555569.1:72 GeneID: 64430 HGNC/MGI_ID: HGNC:20349 UniProt_ID: Nearer transcript ids and distances: ENST00000556907.1:-120 ENST00000406949.5:-170 AK095489:-170 ENST00000406854.6:-174 NM_001330177.2:-174 ENST00000391611.6:-178 ENST00000317623.8:-186 NM_022495.5:-186 view more...

Gene_name: pecanex 4 Gene_symbol: PCNX4 Gene_synonyms: Gene_source: HGNC:20349

TATA-Box annotation

---

Distance to TSS:	182
Nearest PromoterID:	NM_001330177
Entrez ID:	64430
Nearest Unigene:	Hs.509499
Nearest Refseq:	NM_022495
Nearest Ensembl:	ENSG00000126773
Gene Name:	pecanex 4
Gene Alias:	C14orf135|FBP2|PCNXL4
Gene Type:	protein-coding
CpG%:	0.058824
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PCNX4 p2@PCNX4 p3@PCNX4 p4@PCNX4 p5@PCNX4 p6@PCNX4 p7@PCNX4
Sample		p1@PCNX4	p2@PCNX4	p3@PCNX4	p4@PCNX4	p5@PCNX4	p6@PCNX4	p7@PCNX4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	19.09	5.65	1.36	0.39	0.00	0.19	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	18.01	5.06	0.81	0.20	0.20	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.99	3.67	0.39	1.16	0.00	0.39	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	18.50	3.12	0.83	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.37	3.60	0.90	0.22	0.22	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.02	3.10	0.58	0.58	0.58	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.51	6.54	1.96	1.31	0.22	0.44	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	16.96	3.88	0.48	0.97	0.48	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	14.32	5.56	0.85	1.50	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.75	11.01	5.22	0.58	0.00	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.72	8.49	6.47	2.02	0.81	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	10.98	10.98	6.10	1.22	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.47	4.19	1.93	1.29	0.48	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.82	4.81	2.26	0.75	0.00	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.66	4.39	2.20	0.66	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.14	4.28	1.76	1.01	0.00	0.50	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.86	3.49	1.75	0.87	0.00	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	22.36	4.64	2.95	0.42	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	24.53	4.27	2.67	1.07	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.67	3.76	2.11	0.60	0.30	1.05	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	29.14	4.95	2.41	0.53	0.40	0.40	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	22.10	4.32	2.59	1.38	0.17	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.62	3.23	2.59	0.65	0.00	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.60	4.37	1.94	0.49	0.73	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.38	4.90	1.29	0.77	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.89	4.11	1.58	0.95	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.67	4.40	2.75	0.55	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.99	5.42	3.06	0.94	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	22.29	4.20	0.97	0.81	0.16	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.17	4.89	3.08	1.09	0.00	1.09	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	21.56	4.40	1.47	0.84	0.21	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	21.30	4.10	0.98	0.59	0.00	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	23.42	3.38	1.27	0.84	0.00	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.45	3.13	2.47	1.81	0.16	0.49	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	15.71	2.80	1.87	0.75	0.19	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	22.04	3.83	1.34	0.77	0.00	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	20.23	2.66	3.47	1.43	0.00	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.14	2.01	2.22	0.40	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	23.50	3.78	0.81	1.08	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	20.89	2.64	1.44	0.72	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.82	3.53	1.65	0.47	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	21.08	2.93	2.78	0.29	0.15	0.15	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.93	2.95	1.05	0.21	0.00	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	22.73	3.85	2.10	1.05	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.30	3.41	2.21	0.40	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.98	2.56	2.09	0.23	0.00	0.23	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	23.27	3.84	0.96	0.72	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	23.84	3.28	1.19	0.60	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	25.13	2.15	1.20	1.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	19.61	4.45	1.42	1.82	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.73	3.28	1.84	0.82	0.61	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	29.13	4.45	1.11	0.67	0.22	0.44	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	41.98	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	25.90	4.61	0.71	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.21	3.98	1.33	0.66	0.00	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.13	3.36	6.71	2.52	0.00	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	4.59	1.38	1.38	0.00	0.00	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	26.25	2.92	2.92	0.65	0.00	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	30.19	3.53	0.96	0.96	0.00	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	17.92	2.83	3.46	1.26	0.63	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.97	7.76	1.41	2.12	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.24	3.93	1.12	0.56	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	6.37	3.18	7.17	3.18	0.00	0.80	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.75	4.42	1.70	0.68	0.00	1.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	42.56	4.55	1.62	0.97	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.53	4.97	2.13	2.48	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	15.79	0.00	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.74	2.93	4.88	0.49	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	24.79	5.45	2.48	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	24.86	2.81	4.69	2.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.52	3.64	6.29	0.99	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	28.77	4.64	2.47	1.24	0.93	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	32.71	2.75	2.45	1.22	0.31	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	22.65	4.75	3.48	0.79	0.00	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	16.68	3.53	1.93	1.44	0.32	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	25.70	6.74	2.29	1.91	0.13	0.89	0.00
Adipocyte - omental, donor2	11474-119C7	15.70	3.74	0.75	0.75	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	3.68	1.34	0.33	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	14.04	5.10	1.28	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	3.16	0.90	1.35	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	6.08	3.30	0.17	0.00	0.00	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	26.79	8.41	2.74	1.37	0.59	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	18.79	6.43	1.80	1.54	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	15.33	5.58	1.39	1.39	0.28	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	14.70	2.35	2.35	0.00	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	14.08	4.34	0.88	1.21	0.24	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	14.20	3.87	1.61	2.26	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	13.33	3.20	1.07	1.60	0.00	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	8.90	1.11	1.11	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	8.73	2.91	0.42	0.42	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.80	2.01	1.51	0.25	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	6.87	2.95	0.98	0.65	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.31	0.91	0.00	0.30	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.48	2.87	0.22	0.44	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	0.00	0.00	1.08	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	22.49	4.68	2.52	1.08	0.54	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.09	2.67	1.23	0.21	0.21	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	19.34	5.72	2.52	1.49	0.00	0.80	0.23
Anulus Pulposus Cell, donor2	11463-119B5	16.16	4.65	1.47	0.73	0.24	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.73	2.25	1.80	0.90	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	2.60	1.30	1.74	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	6.42	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.26	2.39	2.69	1.20	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	1.26	5.06	1.26	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	1.32	1.98	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.29	3.57	1.30	1.62	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.17	3.40	0.49	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	2.38	0.59	0.00	0.00	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.95	3.01	0.75	0.75	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	16.69	5.08	0.73	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	1.25	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	20.43	4.94	2.47	2.14	0.33	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	2.73	1.36	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	23.07	3.17	0.90	1.06	0.30	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	14.47	3.75	2.68	1.61	0.00	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.82	3.59	1.51	2.08	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.31	1.60	1.60	1.07	0.27	0.27	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	7.80	1.95	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.09	4.15	2.65	0.33	0.00	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	0.00	1.20	2.40	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	3.54	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.53	3.43	2.23	0.34	0.17	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	15.05	2.91	0.97	1.46	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.21	3.42	2.28	0.76	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	2.42	1.21	0.00	1.21	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	2.85	3.42	2.28	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.18	3.42	2.57	0.21	0.00	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.39	2.06	0.77	0.26	0.26	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	0.94	0.94	0.00	0.00	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	2.57	1.29	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	1.43	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.79	2.92	1.75	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.26	3.31	1.51	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	4.75	3.56	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.77	2.54	0.51	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.24	3.82	1.78	0.00	0.51	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	1.27	1.27	1.91	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.42	2.59	0.86	2.16	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.66	1.69	1.69	0.00	0.21	0.42	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.66	1.74	0.87	0.58	0.29	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	14.17	1.89	0.94	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.27	3.39	1.36	0.85	0.17	0.34	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	4.63	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	6.34	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	16.94	3.00	1.93	2.14	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.85	4.81	2.41	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	0.73	3.64	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.01	2.76	1.61	1.61	0.00	0.23	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	5.10	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	23.14	5.34	2.54	1.53	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.93	2.68	0.62	0.83	0.21	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.99	1.84	0.61	0.61	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.60	3.35	2.39	0.96	0.00	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.41	2.00	2.22	0.67	0.00	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	0.00	1.53	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	1.66	2.22	0.55	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.15	4.50	0.26	1.06	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	16.36	2.18	0.73	0.73	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	21.25	4.30	0.61	0.74	0.12	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	15.75	3.42	0.68	0.86	0.17	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	10.28	1.26	0.42	0.21	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	37.30	10.11	2.09	1.39	0.70	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	27.83	7.28	1.62	1.62	0.97	0.00	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	28.49	8.50	1.79	1.34	0.45	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	28.56	6.19	5.96	0.57	1.15	0.69	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.06	6.51	4.76	0.25	0.88	0.88	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.10	7.28	4.89	1.02	0.68	0.80	0.23
Basophils, donor1	12241-129G9	11.51	2.35	0.78	0.52	0.26	0.00	0.00
Basophils, donor2	12242-129H1	19.48	5.77	0.72	1.08	0.36	0.00	0.00
Basophils, donor3	12243-129H2	14.85	4.56	0.73	0.15	0.29	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	3.02	1.08	0.22	0.43	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	0.46	0.46	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	1.88	0.00	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.49	2.29	0.42	0.62	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	7.83	2.99	0.92	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	7.02	1.80	2.70	0.54	0.90	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	25.25	13.19	1.85	0.72	1.85	0.10	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	42.85	22.59	2.33	2.10	2.10	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	32.94	13.11	3.84	1.28	1.92	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	4.51	2.82	0.00	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	9.84	3.53	0.56	0.19	0.19	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	14.71	4.83	0.88	0.44	0.44	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	19.25	7.36	4.81	1.98	0.00	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.88	7.20	5.69	1.52	0.00	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	25.64	4.93	2.63	1.31	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	44.67	6.94	3.04	1.73	0.58	1.01	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	31.08	7.24	4.53	3.02	0.00	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	37.19	6.87	4.50	0.71	0.24	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	35.66	5.36	2.85	1.00	0.33	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	41.68	4.97	3.86	1.66	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	44.38	3.47	2.48	1.49	0.25	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	36.61	2.35	1.96	0.59	0.00	0.78	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	40.24	4.10	1.96	0.89	0.89	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	51.58	5.44	2.83	0.87	0.44	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	30.90	4.45	1.64	0.47	0.00	0.94	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	54.39	4.22	2.64	0.00	0.53	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	39.94	1.11	3.33	0.00	0.00	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	35.25	6.69	2.97	1.49	0.45	1.64	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	38.51	7.18	3.19	1.80	0.40	0.60	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	40.18	6.04	2.50	2.50	0.00	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	29.28	2.52	3.20	1.83	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	44.34	3.39	3.17	1.58	0.23	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	29.24	3.06	1.75	0.87	0.87	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	33.09	5.65	4.03	0.81	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	47.98	4.88	4.71	3.14	0.52	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	45.03	5.47	4.63	2.10	0.42	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	17.09	2.94	0.92	1.10	0.18	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	28.89	2.47	1.06	1.06	0.70	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	17.99	1.32	0.00	0.44	0.44	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	41.68	4.18	4.18	0.35	0.70	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	46.46	4.09	3.72	1.49	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	60.57	5.39	4.53	1.51	0.43	1.51	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.02	1.23	1.64	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	21.79	3.01	1.62	0.93	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	18.33	2.55	0.70	1.16	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	11.99	2.83	1.31	1.31	0.22	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	12.01	4.85	0.92	0.46	0.23	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	11.05	2.17	1.30	0.22	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	19.31	6.38	2.18	1.25	0.62	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	16.59	5.76	1.22	0.70	0.52	0.70	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	23.86	5.80	2.01	1.78	0.67	1.34	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	17.35	3.57	1.02	0.77	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	17.13	3.51	0.88	0.22	0.22	0.22	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	15.58	4.84	1.05	0.84	0.21	0.63	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	4.06	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	21.02	6.78	0.68	0.00	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	1.04	2.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	33.05	10.13	0.53	1.07	1.07	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	6.97	0.00	0.00	0.54	1.61	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	16.85	2.11	0.00	0.00	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	19.61	7.06	0.78	0.00	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	26.37	1.32	0.00	0.00	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	38.63	4.11	3.29	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	29.02	10.88	1.45	0.73	1.45	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	37.86	5.55	1.51	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	30.30	4.85	2.42	0.40	0.81	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.97	2.00	2.80	0.00	1.20	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	20.08	10.04	3.01	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	11.80	3.37	2.25	0.00	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	29.31	13.53	6.39	1.88	3.01	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	43.74	16.69	5.86	0.68	3.16	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	32.49	6.78	0.71	0.00	0.00	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	22.66	6.12	3.06	0.00	0.61	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	29.58	6.40	3.05	0.91	0.61	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	28.84	5.62	1.02	2.55	0.26	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	33.91	7.41	0.90	0.45	0.90	0.22	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	27.88	9.49	0.86	1.15	1.44	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	41.25	4.74	0.95	1.90	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	33.71	9.13	1.40	0.70	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	72.52	3.30	6.59	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	19.80	5.93	3.32	1.59	0.72	0.29	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	21.18	3.90	1.36	0.17	0.17	0.85	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	20.63	4.35	1.61	0.48	0.64	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	23.31	7.17	1.34	0.45	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.95	6.99	1.05	0.35	1.05	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	33.44	12.32	1.76	1.76	2.64	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	28.67	8.01	2.53	0.00	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	16.21	6.65	2.29	0.83	0.21	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.40	3.68	1.34	1.00	1.00	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	59.83	10.88	0.54	0.82	1.36	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	56.27	10.18	0.54	0.54	2.68	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	66.35	1.79	3.59	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	30.41	8.53	2.23	0.37	1.30	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.88	7.58	1.73	1.30	0.87	1.08	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.48	6.30	1.26	0.63	0.63	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	39.94	9.61	1.52	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	29.03	8.67	1.30	0.87	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.27	9.15	1.74	0.87	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	46.02	7.42	1.48	0.00	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	8.31	0.92	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	8.37	0.00	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	36.28	11.08	0.28	0.83	2.77	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	40.24	11.78	0.25	0.74	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	24.64	6.16	0.00	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	35.10	9.31	1.43	0.72	1.07	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	31.85	4.15	0.00	1.38	5.54	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	34.38	8.18	1.96	0.00	0.98	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	21.78	6.76	1.88	1.13	0.38	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	30.80	6.82	0.50	0.76	1.26	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.08	2.75	0.69	0.46	0.23	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.10	3.35	0.72	0.00	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	14.23	2.19	0.82	0.00	0.55	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.71	3.90	2.70	0.30	0.30	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	14.16	1.92	0.72	0.96	0.24	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.82	4.09	0.91	0.45	0.23	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	13.69	3.04	1.96	0.00	0.43	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.11	1.84	1.84	0.00	0.26	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.97	2.81	1.17	0.23	0.00	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.79	2.11	3.92	0.60	0.30	0.91	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.46	4.36	3.49	0.29	0.00	0.87	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.39	3.46	3.20	0.53	0.80	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	31.52	4.82	7.44	0.00	0.00	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.77	5.47	10.02	0.46	1.37	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	4.48	10.44	0.75	0.75	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	13.33	3.24	2.88	0.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.24	2.88	0.86	0.29	0.00	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	10.84	3.54	0.71	0.71	0.00	0.94	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	12.68	4.12	2.54	0.32	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.46	5.54	3.38	0.31	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	12.50	3.85	2.24	0.64	0.32	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.83	3.44	3.82	2.29	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.40	5.52	4.34	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	6.05	0.00	1.51	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	69.86	16.06	25.69	6.42	0.00	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.26	9.09	25.88	0.00	1.40	2.10	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	77.13	23.04	33.06	5.01	0.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	10.97	1.83	1.83	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	14.33	3.95	1.48	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	15.89	4.00	0.84	0.84	0.00	0.21	0.11
Chondrocyte - de diff, donor1	11261-116G1	17.33	7.63	4.16	1.39	1.04	1.39	0.00
Chondrocyte - de diff, donor2	11338-117F6	16.35	1.78	1.07	1.07	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	17.18	3.75	2.05	1.25	0.46	0.57	0.11
Chondrocyte - re diff, donor2	11339-117F7	45.66	8.06	2.69	1.79	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	21.43	7.28	7.28	1.62	0.40	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	47.28	11.02	5.39	3.21	0.69	0.57	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	32.49	7.05	4.28	2.57	0.86	0.64	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	40.80	6.73	4.07	2.04	0.35	0.53	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	28.06	12.01	3.21	2.11	0.92	0.73	0.18
Corneal Epithelial Cells, donor1	11526-119I5	2.85	0.88	0.00	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	0.00	1.14	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	3.83	2.30	0.26	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.91	1.65	0.66	0.33	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.78	2.21	0.32	0.32	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	10.47	2.27	0.97	0.76	0.11	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	31.43	6.49	1.71	0.00	1.37	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.81	5.88	1.31	0.00	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.55	6.29	0.97	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	11.67	2.84	0.33	0.33	0.00	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	2.35	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.57	1.41	0.57	0.57	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.80	1.18	0.39	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	9.89	1.75	0.58	0.58	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	10.35	1.65	0.24	0.24	0.24	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	10.69	2.10	0.70	0.70	0.53	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	25.27	5.32	3.32	1.33	0.44	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.21	5.48	1.52	0.91	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	44.26	7.89	3.95	1.13	0.28	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	17.83	4.75	2.67	1.49	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	16.66	1.56	0.52	0.00	1.56	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	11.06	3.69	1.84	1.28	0.00	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	17.21	6.80	1.20	1.60	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	2.10	0.00	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.34	7.58	1.62	2.11	0.37	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	15.21	4.13	0.00	0.22	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.17	4.27	0.37	0.37	0.73	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	6.83	2.28	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.18	1.40	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.78	4.40	0.16	0.47	0.31	0.00	0.00
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	56.11	6.60	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	39.24	3.57	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.64	0.49	0.49	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.53	5.75	4.52	0.82	0.41	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.31	1.75	0.66	0.66	0.22	0.33	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.37	1.30	0.33	0.54	0.33	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.31	5.58	1.82	0.73	0.49	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	56.09	6.96	6.14	2.73	0.41	0.82	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.14	2.64	1.37	1.16	0.11	0.21	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	49.01	7.64	9.22	3.43	1.05	1.32	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.61	4.32	0.66	1.00	1.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	21.32	3.63	1.36	0.91	0.00	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	3.03	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.98	2.68	1.26	0.79	0.16	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	32.74	8.18	1.52	1.82	1.52	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	21.70	7.36	1.40	1.78	0.63	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	20.62	6.06	1.82	0.61	0.30	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	19.83	5.09	2.01	1.07	0.40	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	19.41	3.88	1.29	0.43	0.00	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	7.32	2.93	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	8.07	10.15	1.38	0.46	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	23.24	7.29	2.37	1.36	1.53	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	15.73	4.70	0.94	0.70	0.70	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	11.32	4.25	0.47	1.89	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	14.63	6.29	0.48	0.85	0.24	0.00	0.12
Fibroblast - Dermal, donor4	11450-119A1	18.31	14.58	1.47	2.37	0.68	0.34	0.23
Fibroblast - Dermal, donor5	11454-119A5	18.67	13.43	2.44	1.74	0.70	0.70	0.00
Fibroblast - Dermal, donor6	11458-119A9	17.38	10.56	1.14	2.44	0.81	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	30.61	8.54	1.67	2.50	0.62	0.83	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	39.56	6.29	2.36	3.14	1.05	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	26.88	8.70	1.71	2.24	1.32	0.79	0.13
Fibroblast - Gingival, donor3	11394-118C8	19.63	10.06	3.96	1.45	0.48	0.68	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	7.27	3.12	2.08	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.44	3.88	0.70	0.70	0.18	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	37.10	8.26	2.18	2.03	0.31	1.09	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	30.16	6.63	2.84	1.89	1.08	0.81	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	47.64	5.65	1.76	1.06	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.06	5.85	0.73	0.73	0.88	1.02	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.82	5.05	2.45	1.36	0.95	0.82	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	30.39	7.13	1.86	2.19	0.77	0.55	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.72	5.14	2.64	1.91	0.44	0.59	0.44
Fibroblast - Lung, donor1	11270-116H1	10.87	1.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	20.89	13.43	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	19.20	6.12	1.06	1.06	0.00	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	21.66	5.00	0.83	3.33	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	1.40	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.28	3.08	0.28	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	23.95	2.84	1.62	1.22	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.16	11.64	1.75	1.75	1.16	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	27.00	12.44	1.67	1.37	0.91	0.30	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	61.20	18.05	6.12	3.67	0.61	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.90	4.58	1.53	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.82	2.43	0.81	1.35	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.44	3.13	0.93	0.46	0.00	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	18.90	4.97	1.55	0.99	0.22	0.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	28.85	4.06	2.24	2.44	0.61	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	6.68	2.67	0.67	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	5.54	1.98	0.00	0.40	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	48.22	8.93	7.74	2.58	0.60	2.18	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	26.64	5.33	2.13	1.78	0.53	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.17	4.34	1.38	1.77	0.59	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.92	12.34	9.93	4.21	0.60	1.50	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.72	8.96	3.56	1.94	0.43	0.65	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	30.37	5.82	3.29	1.27	0.00	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	22.64	2.46	2.13	1.97	0.33	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	50.93	18.85	9.62	1.80	2.01	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	23.41	5.63	3.01	1.00	0.10	0.50	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	44.13	10.88	7.25	1.51	0.91	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.24	5.14	3.65	0.99	0.33	0.33	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.86	4.79	4.79	2.39	0.17	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	43.68	9.20	8.54	3.28	0.99	1.64	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.69	6.28	3.20	1.28	0.21	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	17.37	4.39	1.86	1.18	0.34	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	8.15	3.92	1.73	0.63	0.00	0.78	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	6.10	1.74	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.44	5.89	4.85	1.39	0.17	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	23.42	11.19	4.68	1.82	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	24.02	5.37	0.51	1.28	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	7.66	0.77	2.30	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	3.19	1.28	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	21.68	7.99	1.71	0.86	2.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	35.85	8.55	2.48	0.83	1.10	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	44.52	8.68	3.42	0.91	2.28	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	20.21	4.76	1.59	0.79	0.40	0.20	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	33.57	6.08	1.85	1.06	2.38	0.79	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	51.21	12.07	4.24	0.65	1.63	1.63	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	17.25	3.10	0.88	0.88	2.21	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.41	7.77	1.27	0.42	1.70	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	16.75	6.77	2.83	1.11	1.11	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	12.36	3.76	1.07	0.00	2.15	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	20.32	7.43	1.86	2.23	0.74	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	19.38	5.68	2.08	1.25	1.25	0.28	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.38	4.47	1.63	1.02	0.61	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	17.34	6.62	1.60	0.68	0.23	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	18.31	6.73	1.49	1.12	0.50	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	16.39	5.68	1.09	1.53	0.00	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	21.27	5.61	2.07	0.59	0.89	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.96	6.04	1.59	0.95	1.59	0.48	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	18.99	3.13	2.23	0.45	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	21.98	4.23	2.62	1.61	0.60	0.81	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.58	7.46	3.39	1.36	0.85	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	29.79	8.60	3.72	1.60	0.62	0.62	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.15	6.66	3.85	1.14	0.94	0.73	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.76	7.00	4.78	1.54	0.68	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.56	6.42	3.32	1.22	0.33	0.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	25.46	8.49	1.75	1.75	0.75	0.58	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.16	8.78	2.65	1.84	0.41	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.46	5.78	2.68	1.03	0.62	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	21.91	5.42	3.80	1.50	0.46	0.58	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.85	8.17	3.17	1.00	0.50	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	19.40	3.31	2.87	0.22	0.00	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.54	5.53	4.18	1.11	0.37	1.23	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	23.67	5.84	3.08	0.97	0.16	1.13	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	20.53	3.85	2.89	1.28	0.64	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.42	5.31	1.99	1.14	0.28	0.66	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	3.95	1.58	0.79	0.47	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	17.94	5.17	4.26	1.52	0.00	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.55	6.38	3.66	1.05	0.31	0.42	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.00	4.61	2.42	1.32	0.22	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.41	3.37	5.61	0.00	0.56	1.40	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	17.78	5.28	1.48	1.94	0.28	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.97	5.08	3.21	0.27	0.53	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	17.14	5.36	1.38	2.14	0.92	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	14.51	5.83	2.33	1.17	0.52	0.65	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.37	7.86	2.17	1.63	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	17.51	5.90	2.03	1.11	0.18	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.27	4.17	3.95	0.88	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	25.79	1.98	2.98	0.99	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.62	6.46	3.56	2.11	0.53	0.92	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	18.76	5.45	3.23	0.61	1.21	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.57	9.40	8.13	2.80	0.76	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	13.54	9.55	0.80	0.40	1.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	13.56	7.55	0.31	0.46	1.08	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.37	7.98	1.02	0.61	2.45	0.20	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.09	5.01	0.00	0.31	1.56	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.89	3.67	0.57	0.57	0.57	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	20.29	7.84	0.46	4.15	1.38	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	7.42	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.53	9.67	1.16	1.55	1.55	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	6.42	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	6.96	1.74	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.46	5.53	0.33	0.65	1.63	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	21.83	7.82	0.41	0.41	0.82	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	6.66	6.66	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.08	6.71	0.84	1.40	0.56	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	23.21	5.88	0.65	0.98	1.63	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	32.71	7.55	0.84	1.68	0.84	0.00	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	31.49	9.22	1.27	1.91	1.91	0.00	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.06	5.43	2.72	2.72	1.02	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	10.44	2.09	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	24.63	8.02	0.57	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.39	3.26	0.00	0.89	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	10.16	5.08	3.39	0.00	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.48	11.60	3.31	2.49	0.83	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	27.85	9.44	3.45	1.15	0.69	0.23	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	15.81	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	31.14	8.46	2.69	0.38	0.38	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.92	10.76	0.33	2.28	0.98	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	31.44	8.69	2.68	1.34	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.97	5.01	1.93	1.54	0.39	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	47.59	7.19	4.79	3.42	1.03	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	7.45	4.97	0.00	0.00	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	26.90	9.91	4.25	0.94	1.42	0.47	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	25.35	4.83	1.21	0.00	1.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	37.64	7.63	3.05	0.00	0.51	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	29.91	5.18	1.60	2.79	1.99	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	33.05	6.41	1.97	0.99	1.97	0.49	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	42.50	2.36	1.18	0.00	0.00	0.00	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	20.42	4.67	1.75	3.50	0.58	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	37.30	4.83	0.88	1.32	1.32	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	28.82	3.39	2.54	1.70	0.85	2.54	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	29.85	2.98	1.79	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.47	5.34	0.97	0.97	0.49	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	1.14	3.42	1.14	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	15.80	2.08	0.42	0.42	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15.74	2.25	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.64	3.81	1.90	0.95	0.63	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	11.70	2.51	0.84	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	10.79	3.02	0.23	0.70	0.46	0.46	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.35	1.52	0.51	0.34	0.84	0.34	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	11.15	3.87	0.46	1.14	0.23	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.17	2.40	0.55	0.87	0.66	0.11	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.39	1.07	0.21	0.43	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.12	3.44	0.86	0.22	0.22	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	10.59	1.49	0.37	0.37	0.12	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.72	1.20	0.17	1.03	0.00	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.37	1.92	0.96	0.00	0.96	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	1.68	0.56	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	0.87	0.00	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	5.29	0.00	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.87	1.76	1.06	1.06	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	1.45	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.53	5.59	1.75	1.57	0.52	0.52	0.00
Hepatocyte, donor1	11523-119I2	10.90	3.63	2.42	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	10.77	2.15	1.08	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	14.11	0.61	1.23	0.61	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	35.25	5.87	0.00	0.00	4.57	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	32.16	11.36	3.67	2.10	0.52	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.43	5.90	0.69	1.65	0.14	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	8.12	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	8.34	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	3.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	4.41	1.26	0.00	1.26	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	11.63	0.65	0.00	0.00	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	3.26	0.81	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.30	2.10	0.00	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	3.21	0.00	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.72	1.42	0.47	0.00	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	0.91	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	1.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	8.89	2.54	0.00	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	6.38	1.91	0.00	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	1.82	0.00	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	2.86	0.00	1.43	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.57	0.62	0.31	0.62	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	10.54	3.51	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	2.09	0.00	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	6.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	3.49	0.00	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	4.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	6.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	4.27	0.00	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	6.44	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	3.03	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	14.44	4.81	1.47	0.73	0.41	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	6.44	1.17	0.00	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	11.07	5.49	0.95	0.76	0.66	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	18.73	6.47	4.77	0.45	1.14	0.23	0.11
Keratocytes, donor1	11527-119I6	5.50	9.28	1.38	0.34	0.34	1.03	0.00
Keratocytes, donor2	11607-120I5	3.52	1.17	1.17	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	13.04	6.72	3.36	1.58	0.59	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	17.26	5.39	3.24	0.00	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	30.10	9.11	2.88	1.85	0.81	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	29.16	4.84	1.72	1.61	0.30	0.40	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.74	4.27	1.42	1.19	0.12	0.47	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.60	3.07	1.40	1.67	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	20.15	6.93	1.73	0.79	0.79	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	13.98	5.91	3.23	0.00	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	2.84	1.26	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.65	1.62	0.75	0.32	0.22	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.47	6.16	2.87	0.41	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.33	1.52	0.25	0.51	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.15	3.66	1.27	0.42	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.99	5.14	2.77	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.35	3.10	0.39	0.97	0.00	0.39	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.37	0.93	0.93	0.56	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	14.63	4.18	2.44	1.05	0.00	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.93	2.86	0.95	1.19	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.36	1.37	0.55	0.41	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.25	3.70	1.23	1.85	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.79	0.94	0.00	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.78	3.66	1.10	0.18	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.78	3.62	0.33	0.66	0.33	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.08	1.17	0.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.48	1.00	0.50	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.49	6.30	2.91	1.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.69	2.42	0.54	0.27	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.93	2.42	1.06	0.91	0.15	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.44	4.67	1.04	0.00	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.45	4.82	1.26	0.42	0.63	1.05	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.97	2.41	1.35	0.15	0.00	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	13.76	3.44	0.69	0.00	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.73	2.07	0.38	0.19	0.38	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.32	1.17	0.53	0.21	0.32	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.90	3.39	1.45	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	11.25	2.32	0.33	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.19	1.73	0.99	0.37	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	19.99	7.77	2.22	1.85	0.74	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.65	1.73	2.22	0.49	0.99	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.56	1.79	0.14	0.27	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	21.55	6.75	1.93	1.61	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.83	3.96	2.43	0.91	0.30	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.88	3.08	1.68	0.56	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.07	5.33	2.13	1.78	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.70	1.94	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.00	1.40	0.16	0.47	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	16.11	2.15	2.15	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.74	2.61	1.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.77	0.94	0.24	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	17.70	5.45	1.11	0.99	0.12	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.94	2.82	0.26	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.16	2.09	0.90	0.90	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	0.74	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.35	1.69	0.42	0.00	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.77	0.70	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.88	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	17.19	2.04	0.68	0.00	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	13.96	1.16	0.29	0.29	0.58	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.56	0.90	0.00	0.45	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	17.34	1.35	0.54	0.41	0.14	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.81	2.05	0.51	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.58	1.06	0.00	0.71	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.99	1.33	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.26	1.53	0.00	0.00	1.02	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	17.08	2.13	0.27	0.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.12	2.46	0.38	0.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	0.61	0.61	0.61	0.00	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	1.63	0.82	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.62	1.67	0.42	0.00	0.00	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.62	2.24	0.28	0.84	0.56	0.28	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	2.06	0.00	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	15.97	1.74	0.00	0.00	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	13.45	3.29	0.00	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	18.81	3.32	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.03	2.12	0.00	0.35	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	16.23	2.21	0.37	0.00	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.05	1.15	0.38	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.98	1.70	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.03	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	1.81	0.90	1.36	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	14.36	3.59	0.00	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	0.75	0.00	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	12.26	0.74	0.00	0.00	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.35	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.98	0.86	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	11.33	3.00	0.33	0.33	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.27	0.60	0.60	0.60	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	1.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	13.06	1.72	1.37	0.34	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	10.73	1.61	0.00	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	14.14	0.67	0.00	1.35	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	14.45	1.11	0.37	0.00	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	0.00	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.41	0.80	0.00	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14.54	0.73	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	2.30	0.77	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	11.84	2.96	0.49	0.00	0.00	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	1.88	0.00	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	16.59	1.01	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	1.35	0.90	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	24.05	3.12	0.89	0.45	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.03	2.74	0.39	0.00	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	16.49	1.98	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	13.49	1.04	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.25	1.31	0.44	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.77	1.68	0.00	0.00	0.56	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	21.64	0.88	0.00	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.43	2.31	0.39	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.19	3.04	0.00	0.00	0.00	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	17.78	1.44	0.48	0.00	0.00	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.31	1.99	0.00	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	1.82	0.00	0.61	1.22	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	10.38	0.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	14.06	0.76	0.00	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.46	2.07	0.52	0.52	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.14	1.81	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	17.75	0.32	0.63	0.63	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	0.53	0.53	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.94	1.15	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	0.51	0.00	0.00	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.85	1.41	0.71	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	1.13	0.57	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	2.91	0.00	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	16.44	2.35	2.35	0.00	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.28	2.09	0.42	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.51	1.39	0.46	0.00	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.71	0.00	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.44	2.67	0.53	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.95	3.23	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	23.86	0.00	0.00	0.92	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	17.78	0.89	0.00	0.00	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.10	2.28	1.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	19.17	3.83	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	0.55	0.55	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	14.70	1.78	0.00	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	18.72	1.82	0.26	0.00	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	14.59	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	2.08	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	20.51	6.15	4.33	1.37	0.46	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	12.11	2.20	1.10	1.10	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	15.21	4.85	1.18	1.31	0.39	0.66	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.87	5.84	1.06	1.06	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	23.77	7.92	10.62	4.28	0.48	0.79	0.32
Mallassez-derived cells, donor3	11930-125I4	18.90	7.51	2.92	2.64	0.14	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	17.04	13.35	15.35	2.29	0.90	0.70	0.00
Mammary Epithelial Cell, donor2	11350-117G9	13.90	11.58	9.27	3.19	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	11.47	4.49	1.75	1.50	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	121.35	13.56	40.00	6.78	1.36	2.03	0.00
Mast cell, donor1	11563-120D6	23.03	8.54	10.71	1.41	0.65	0.11	0.00
Mast cell, donor2	11565-120D8	63.30	9.81	10.10	2.97	2.08	2.67	0.00
Mast cell, donor3	11566-120D9	62.13	17.33	9.00	1.58	2.70	1.80	0.00
Mast cell, donor4	11567-120E1	63.65	8.16	7.80	2.48	0.53	1.06	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	35.49	6.43	7.65	2.55	1.22	1.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	30.94	6.42	2.33	1.17	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	32.35	9.64	8.26	1.61	0.46	1.49	0.11
Mast cell, expanded, donor8	11941-126A6	27.45	7.36	5.02	1.51	0.33	1.34	0.00
Melanocyte - dark, donor1	11502-119F8	19.40	6.27	1.89	0.90	0.60	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	13.15	2.77	0.35	1.38	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	23.25	16.30	2.61	1.74	1.52	0.14	0.00
Melanocyte - light, donor1	11274-116H5	13.87	4.47	0.94	0.47	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.24	4.09	0.68	1.36	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	0.00	1.73	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	19.26	5.83	0.83	0.94	0.52	0.21	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	20.44	12.10	3.77	2.69	1.34	0.81	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	30.27	9.64	1.87	1.61	1.07	0.54	0.00
Meningeal Cells, donor1	11493-119E8	29.65	6.33	0.87	2.23	0.12	0.25	0.00
Meningeal Cells, donor2	11573-120E7	28.61	9.68	1.32	1.76	0.00	0.88	0.00
Meningeal Cells, donor3	11654-122E7	32.03	7.42	1.39	1.55	0.82	0.16	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.25	10.55	1.43	0.57	0.29	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	30.19	5.33	3.62	1.91	0.40	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	3.94	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	9.33	7.18	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.97	4.87	4.66	0.85	0.21	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.59	3.02	1.01	1.01	0.00	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.21	4.18	0.66	0.22	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	10.23	0.73	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.21	3.68	0.61	0.20	0.41	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.90	6.79	2.77	0.42	0.14	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.15	1.12	0.74	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	35.00	8.55	5.39	1.18	0.13	1.05	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.72	0.30	0.00	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	3.20	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	9.57	6.73	2.13	1.42	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.64	7.51	6.88	1.56	0.00	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	9.43	4.35	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	28.90	3.71	4.51	1.33	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	14.01	2.50	3.00	0.50	0.50	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	21.03	2.82	1.23	0.87	0.07	0.43	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	0.00	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	14.78	3.20	1.72	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.02	1.47	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.30	4.03	2.48	0.62	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.16	2.90	0.00	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.76	3.25	1.25	0.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.17	2.33	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.35	2.64	1.83	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.50	1.19	0.79	0.40	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	4.42	0.88	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	8.74	1.52	1.90	0.00	0.38	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.22	2.97	2.33	1.06	0.00	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	1.84	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.28	1.19	0.30	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.77	3.51	1.51	0.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.89	1.66	1.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	5.53	1.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.98	0.69	2.30	0.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.31	1.89	0.84	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	8.56	1.83	0.41	0.00	0.00	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	7.51	1.07	1.50	0.21	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.78	0.89	0.67	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.10	1.10	0.88	0.00	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	0.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.44	0.82	1.09	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.23	0.88	1.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.17	0.48	0.48	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.21	1.60	1.60	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.51	1.00	1.00	0.50	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.77	3.07	1.31	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	2.56	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	12.64	1.74	2.23	0.99	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	0.70	0.00	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.26	0.34	1.71	1.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	0.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	2.84	2.13	0.36	0.71	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	10.94	2.52	1.12	0.84	0.00	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	10.81	3.74	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	3.50	1.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.75	0.60	0.90	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	12.10	2.09	1.25	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	2.77	0.00	1.85	0.00	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	8.54	1.14	1.14	1.14	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.53	1.80	0.97	0.55	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.26	2.07	1.55	1.81	0.00	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.87	0.43	0.43	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	1.27	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.67	0.80	0.27	1.33	0.00	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.37	2.69	1.50	1.20	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.65	0.85	0.57	0.57	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.60	1.59	1.59	0.64	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.30	1.99	1.77	1.33	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.17	1.52	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.23	2.56	1.42	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	9.59	1.47	1.97	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.87	0.65	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	2.35	1.18	1.76	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.42	2.31	0.86	1.15	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.13	3.30	2.47	0.00	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	13.70	4.17	1.79	0.89	0.30	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	3.77	3.77	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	8.91	5.35	0.00	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.83	5.91	3.94	1.64	0.00	0.33	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	7.36	3.16	0.00	0.00	1.05	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.81	5.34	2.97	0.59	0.00	0.40	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	2.79	2.79	1.86	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.89	3.38	2.25	0.38	0.00	1.50	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.79	2.66	1.07	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.59	4.64	3.39	1.13	0.23	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.84	2.21	1.47	0.74	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	11.36	5.13	2.20	1.47	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	7.78	1.56	1.56	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.09	4.28	2.14	1.07	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	4.04	1.01	1.01	1.01	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.28	2.53	0.84	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	2.72	6.81	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	1.91	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	3.24	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	4.53	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	62.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	16.31	3.26	52.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	19.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	28.01	4.96	1.29	2.80	0.22	1.29	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	18.81	4.18	1.57	2.61	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.69	9.34	2.67	2.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.95	3.34	1.25	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	17.49	5.89	2.47	3.80	0.00	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.88	6.12	2.72	0.68	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	1.84	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	12.56	2.93	2.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	19.76	6.28	1.86	2.09	0.23	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	23.78	7.57	1.08	0.81	0.27	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.86	8.41	1.89	0.84	0.00	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	22.27	11.13	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	4.47	2.48	0.99	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.99	4.06	1.35	1.89	0.00	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.31	3.63	1.36	1.36	0.45	0.91	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.09	6.21	0.49	0.98	0.16	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.96	5.83	2.19	1.09	0.36	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.34	5.30	1.06	1.06	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.21	4.80	1.80	0.60	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	15.75	4.27	2.95	2.63	0.00	0.98	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.75	6.67	1.30	0.98	0.16	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.05	6.70	2.12	1.94	0.18	0.88	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.80	8.44	0.70	0.70	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.99	3.22	1.84	0.46	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.00	6.11	2.57	0.96	0.96	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.24	6.90	2.41	1.03	0.00	1.72	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	20.23	7.59	5.06	5.06	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	25.62	3.79	1.11	1.11	0.22	0.89	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.75	3.39	0.00	0.85	0.85	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.14	3.09	1.19	0.24	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.90	7.73	3.43	1.29	0.86	1.29	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	9.03	9.03	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.99	7.33	2.33	2.67	0.33	1.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.58	3.16	0.00	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.06	3.17	1.19	0.40	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	4.64	1.86	0.00	0.93	1.86	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.78	4.92	3.78	1.14	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	18.58	3.26	1.30	0.65	0.33	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.69	3.92	1.74	0.44	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	4.52	3.62	1.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	20.28	3.53	0.88	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	21.94	6.65	1.33	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.78	8.93	4.46	1.49	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	2.30	2.68	0.77	0.00	1.53	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.31	8.47	3.33	2.42	0.00	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.77	3.76	2.65	1.77	0.00	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.07	5.42	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11	10.22	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	31.70	4.27	1.83	2.44	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	20.46	5.35	0.94	1.57	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.95	4.24	0.61	1.82	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.11	2.37	3.96	1.58	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	11.34	5.67	0.00	0.00	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	27.08	5.59	3.85	2.11	0.50	0.50	0.37
Myoblast, donor2	11322-117D8	27.62	8.06	3.45	1.53	0.58	0.77	0.00
Myoblast, donor3	11398-118D3	33.13	8.58	2.69	3.03	1.01	0.67	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	16.49	5.11	1.90	0.58	0.73	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	39.05	7.38	3.08	0.31	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	19.00	10.25	2.11	0.60	1.21	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	32.03	8.28	2.58	0.00	0.92	0.18	0.00
Neural stem cells, donor1	11275-116H6	66.06	13.07	4.72	4.36	1.45	1.45	0.00
Neural stem cells, donor2	11352-117H2	96.28	15.41	0.00	5.78	3.85	0.00	0.00
Neurons, donor1	11494-119E9	59.17	7.97	1.14	2.28	0.00	2.28	0.00
Neurons, donor2	11574-120E8	43.37	5.72	0.88	1.32	0.88	0.00	0.22
Neurons, donor3	11655-122E8	38.64	3.29	4.93	2.47	0.82	4.11	0.00
Neutrophils, donor1	11233-116C9	24.13	2.78	1.86	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	17.39	2.90	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	31.15	5.50	2.44	0.00	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	20.54	4.99	1.66	0.95	0.12	0.71	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	10.42	3.58	1.30	0.00	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	14.84	4.81	2.01	0.60	0.20	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	12.94	3.30	1.65	1.10	0.14	0.28	0.14
Olfactory epithelial cells, donor2	11934-125I8	20.55	4.63	1.88	1.30	0.29	1.01	0.43
Olfactory epithelial cells, donor3	11935-125I9	19.75	4.88	2.61	0.91	0.11	0.79	0.23
Olfactory epithelial cells, donor4	11936-126A1	21.82	4.77	2.14	1.75	0.39	0.49	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	4.81	2.41	1.81	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	10.63	2.34	0.85	0.85	0.00	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	4.57	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	4.97	1.24	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	8.01	1.95	0.39	0.78	0.39	0.00	0.00
Osteoblast, donor2	11354-117H4	22.47	7.02	4.21	0.70	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	24.35	3.73	0.89	1.24	1.07	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	29.40	10.19	3.71	1.43	0.84	1.01	0.25
Pericytes, donor1	11491-119E6	5.56	1.11	0.67	0.00	0.11	0.00	0.11
Pericytes, donor2	11571-120E5	8.15	0.91	0.68	0.23	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	19.33	2.85	0.41	1.22	0.20	0.00	0.20
Perineurial Cells, donor1	11499-119F5	15.94	6.56	2.03	1.81	0.11	0.11	0.00
Perineurial Cells, donor2	11579-120F4	19.51	4.97	2.02	1.01	0.18	0.55	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	24.22	6.06	0.64	0.64	0.64	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	17.63	2.94	0.24	0.49	0.49	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.05	4.01	0.91	0.52	0.91	0.65	0.13
Placental Epithelial Cells, donor1	11278-116H9	8.85	2.15	0.48	0.72	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	12.20	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.03	1.77	0.79	0.39	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.46	4.75	1.27	0.63	0.00	0.63	0.95
Preadipocyte - breast, donor1	11467-119B9	25.51	5.06	2.44	1.50	0.00	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	37.33	6.79	7.05	2.74	0.26	1.44	0.13
Preadipocyte - breast, donor2	11328-117E5	19.81	5.18	1.58	0.90	0.00	0.68	0.45
Preadipocyte - omental, donor1	11468-119C1	31.43	7.25	3.84	1.70	0.43	0.64	0.00
Preadipocyte - omental, donor2	11329-117E6	24.88	3.49	2.18	0.87	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	32.37	5.01	1.58	1.43	0.29	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	11.81	0.98	0.98	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.13	1.84	0.92	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	18.95	4.25	1.06	1.42	1.06	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	18.39	4.43	0.51	0.68	0.17	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	20.12	7.17	2.61	1.58	0.65	0.75	0.00
Preadipocyte - visceral, donor2	11357-117H7	20.71	3.68	2.30	0.92	0.46	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	10.97	4.39	0.73	0.73	0.10	0.31	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.99	11.62	2.11	0.91	1.06	0.00	0.60
Prostate Epithelial Cells, donor2	11331-117E8	20.18	4.06	3.39	2.17	0.54	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	6.06	1.59	0.55	0.37	0.18	0.00	0.12
Prostate Stromal Cells, donor1	11254-116F3	18.91	4.67	1.37	1.03	0.68	0.57	0.11
Prostate Stromal Cells, donor2	11332-117E9	30.12	5.02	2.69	1.43	0.36	1.08	0.90
Prostate Stromal Cells, donor3	11405-118E1	19.71	4.69	2.09	0.73	0.10	0.31	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	3.28	0.36	0.00	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.37	7.07	2.50	1.04	0.42	0.28	0.14
Renal Epithelial Cells, donor1	11517-119H5	11.16	4.06	0.51	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	2.13	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.02	7.20	1.91	0.85	0.64	0.74	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.16	2.83	0.13	0.27	0.00	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	18.87	6.66	1.33	1.55	0.89	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	4.66	0.67	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.90	1.76	0.66	0.44	0.22	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	0.63	0.63	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	0.55	0.28	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.62	2.68	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	2.11	0.00	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.15	1.54	0.19	0.58	0.19	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	31.37	6.74	1.81	0.52	0.52	0.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.63	2.56	1.42	0.57	0.00	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	9.26	2.06	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.08	4.01	2.01	1.00	0.25	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.92	3.88	1.60	0.67	0.40	0.27	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	13.40	9.83	1.79	0.89	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.12	4.95	4.40	3.30	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	23.20	8.12	2.32	1.16	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	29.13	7.15	1.56	1.56	0.26	0.39	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	26.61	6.45	0.89	1.19	0.50	0.40	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	39.60	7.58	1.12	2.23	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.87	8.68	1.86	1.61	0.25	0.50	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	29.37	6.64	1.17	1.40	0.35	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	34.21	8.32	1.62	0.92	0.69	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	28.75	4.79	1.10	1.10	0.82	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	27.38	4.24	0.91	0.91	0.45	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	38.88	7.88	0.36	1.25	0.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	30.56	6.46	2.30	1.43	0.14	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	23.82	5.90	0.54	1.29	0.75	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	26.99	7.08	1.33	1.55	0.66	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.10	3.63	1.15	1.72	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	26.92	6.99	1.21	0.75	0.56	0.28	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	50.73	8.64	1.32	1.32	0.56	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.96	3.45	0.80	1.19	0.13	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	27.94	7.01	1.07	0.88	0.97	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	31.32	7.07	1.34	0.95	0.57	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	24.88	7.37	1.60	1.17	0.21	0.53	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	24.11	8.41	0.84	0.84	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.93	7.86	1.37	1.71	0.51	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.52	3.28	2.01	0.73	0.36	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	24.89	3.80	0.98	0.98	0.49	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	28.88	8.06	0.54	1.61	0.13	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	31.14	5.43	3.30	3.07	0.47	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	29.37	5.95	1.39	0.99	0.20	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.00	5.38	1.64	1.40	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.92	4.35	0.21	0.62	0.41	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	27.87	9.73	0.44	1.11	0.22	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	23.81	6.68	1.04	1.46	0.63	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	27.99	6.86	2.15	1.62	0.54	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.41	5.96	1.02	0.68	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	29.11	4.82	0.58	0.58	0.39	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.20	5.85	2.58	2.24	0.69	0.52	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.59	6.72	1.51	1.23	0.69	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.10	6.57	1.31	2.13	0.66	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	27.61	4.43	1.02	0.68	0.34	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.82	6.21	1.63	1.48	0.44	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.45	7.73	1.33	0.80	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	20.33	6.08	0.55	1.11	0.41	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	21.43	4.29	0.95	0.48	0.48	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	41.72	8.26	1.21	2.02	0.20	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.57	7.63	1.79	1.51	0.09	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.36	9.43	3.49	1.40	0.35	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	21.46	11.18	2.12	2.42	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	25.95	6.98	2.45	1.71	1.10	0.73	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	60.84	24.60	4.80	3.49	1.75	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.95	10.95	1.83	3.04	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	26.22	9.04	1.81	2.11	0.30	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	20.81	8.82	1.81	0.90	0.45	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	34.15	10.78	2.40	2.40	0.60	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	26.21	13.22	3.42	2.13	0.71	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.63	9.18	2.13	2.13	0.43	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.25	11.42	4.21	0.60	0.00	1.80	0.00
Schwann Cells, donor1	11498-119F4	7.52	2.26	0.94	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	17.01	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	27.17	5.04	0.88	1.53	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	14.79	7.12	0.55	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	7.35	0.92	0.00	0.46	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	7.21	2.06	0.41	0.41	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	24.85	4.97	4.97	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	19.77	2.82	0.00	2.82	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	21.29	6.95	2.11	1.50	0.35	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	6.51	3.61	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	4.18	1.67	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.94	6.76	0.47	0.63	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	12.34	7.58	0.74	0.74	0.89	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	17.70	10.62	1.54	0.77	0.62	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	24.95	16.51	4.66	2.02	1.13	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.26	8.85	1.85	0.86	0.71	0.71	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	19.84	8.53	0.69	1.29	1.59	0.20	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.14	4.63	1.18	0.59	0.51	0.34	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.75	11.58	1.45	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.66	2.20	0.83	0.41	0.14	0.00	0.00
Skin - palm, donor1	10286-104F7	0.00	2.69	0.00	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.11	2.59	0.43	0.86	0.58	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	130.04	23.72	9.81	3.27	3.27	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.48	2.60	0.39	0.39	0.26	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	15.15	5.00	2.22	1.11	0.14	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	12.94	5.91	2.11	0.42	0.42	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	83.10	28.97	7.19	4.23	2.54	0.63	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	9.89	2.77	0.90	0.37	0.00	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.79	1.54	0.31	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	45.13	11.56	12.45	4.89	0.22	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.75	4.70	0.00	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.48	2.43	0.44	0.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.42	3.54	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	6.18	1.55	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	19.01	3.00	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.71	3.33	0.80	0.27	0.00	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	17.51	4.65	2.88	0.89	0.66	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	20.74	5.89	1.28	1.79	0.38	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.35	10.42	4.56	2.28	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	34.26	8.56	1.48	2.66	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.32	4.98	2.14	1.00	0.00	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.95	1.63	0.00	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	15.22	1.83	0.61	0.61	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.37	1.77	1.52	1.01	0.00	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	10.49	1.91	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	39.08	9.14	3.39	1.77	1.18	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	27.98	7.53	2.58	1.94	0.22	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.26	7.87	2.73	1.47	0.94	0.42	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.52	2.01	1.24	0.46	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	2.16	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	13.75	3.29	0.90	0.90	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.90	0.68	0.34	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.87	6.75	1.73	1.18	0.39	0.31	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.54	6.44	1.01	1.61	0.20	0.40	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	23.89	4.10	4.10	2.73	0.00	1.14	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.08	3.62	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	29.67	11.13	2.91	2.12	0.79	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.97	9.32	1.20	1.20	0.53	0.40	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.78	4.26	1.63	1.25	0.13	0.63	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.22	4.57	1.78	1.01	0.25	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.11	3.77	1.36	0.60	0.45	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	2.25	0.75	0.00	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	19.53	5.12	2.79	1.86	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	1.51	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.86	3.76	1.57	1.25	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.90	1.77	0.59	0.29	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.24	7.75	1.17	1.00	1.17	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	18.69	3.74	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.64	1.73	0.43	0.43	0.29	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.02	2.04	0.51	0.76	0.00	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.84	2.07	0.56	0.56	0.56	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	27.39	9.50	3.49	2.10	1.12	0.42	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.72	5.95	2.93	1.17	0.42	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	2.38	0.95	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.58	2.45	1.22	0.00	0.24	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	30.49	5.08	1.77	0.66	0.22	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.31	8.78	2.34	2.93	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.08	5.44	0.97	1.36	0.19	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	24.86	4.50	4.23	2.12	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	20.09	5.58	7.81	2.23	0.00	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	27.67	9.70	5.03	2.16	0.72	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.67	5.68	1.99	2.56	0.28	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	25.21	3.94	2.36	1.58	0.79	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	19.30	4.83	2.03	1.52	0.25	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	25.16	5.59	1.60	2.00	0.40	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	20.90	6.27	2.93	3.76	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	17.88	4.58	1.83	1.83	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	17.67	3.87	1.68	0.50	0.00	0.34	0.00
Synoviocyte, donor2	11368-117I9	9.22	2.68	1.68	0.67	0.00	0.84	0.00
Synoviocyte, donor3	11440-118H9	8.49	2.68	0.67	0.45	0.22	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	6.43	3.22	0.00	0.36	0.36	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	0.00	0.00	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.26	5.33	0.46	0.23	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.25	3.73	1.00	0.50	0.00	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	8.12	2.71	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	2.29	1.15	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	21.78	4.92	2.34	0.49	0.25	0.37	0.12
Urethra, donor2	10319-105A4	32.37	1.80	1.80	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.11	1.06	0.00	0.00	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	5.21	2.00	0.80	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.58	0.92	0.23	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	17.61	5.13	8.25	1.78	0.67	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	18.69	8.01	0.00	0.00	0.00	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	10.01	0.00	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.11	3.42	1.37	0.00	1.37	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.18	5.85	1.03	0.69	0.69	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	17.43	3.49	0.58	1.16	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	20.82	1.04	1.04	2.08	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	25.70	5.51	0.92	0.00	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	17.35	3.65	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	16.65	16.53	1.36	0.99	2.22	0.25	0.25
Wilms' tumor cell line:HFWT	10597-108E3	13.20	0.00	0.00	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.08	8.38	2.79	0.56	1.68	0.28	0.28
achilles tendon, donor2	10292-104G4	14.47	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	26.52	11.22	3.82	1.53	1.53	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	27.40	14.63	2.09	1.16	1.63	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	51.52	9.97	0.71	0.36	2.02	0.12	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	98.51	25.31	5.17	1.36	2.18	0.27	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	24.45	7.03	0.84	0.56	0.84	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	25.59	5.71	1.69	1.27	0.42	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.29	6.26	7.08	0.54	0.27	1.36	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.56	11.02	2.64	1.32	0.88	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	42.88	11.84	4.49	1.23	1.23	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	22.13	15.14	0.39	1.16	3.49	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.81	12.51	0.92	0.55	1.29	0.37	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	23.40	3.90	0.00	11.70	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.43	7.20	0.93	1.39	0.46	0.23	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	18.38	10.10	1.29	0.52	1.04	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	19.29	11.11	0.00	0.29	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.22	8.83	0.46	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	18.92	10.28	1.23	1.23	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.36	1.84	0.61	0.92	0.31	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	17.92	6.40	0.43	0.43	1.71	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.11	9.71	0.61	0.91	1.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.53	8.18	2.41	1.20	2.41	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.14	6.24	1.56	1.56	0.67	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	35.69	4.34	2.33	1.33	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	3.72	1.86	0.00	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	40.68	7.16	1.88	0.38	1.88	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	57.13	28.35	5.67	3.93	3.49	2.18	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	39.36	5.62	5.62	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	25.90	5.18	1.18	0.94	0.24	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	14.27	4.81	1.55	0.78	0.47	0.16	0.31
adipose, donor1	10184-103D4	36.94	10.56	6.45	2.35	1.17	2.93	0.59
adipose, donor2	10185-103D5	30.82	5.27	3.65	2.03	2.03	0.41	0.00
adipose, donor3	10186-103D6	41.39	6.81	4.08	1.36	2.18	1.36	0.27
adipose, donor4	10187-103D7	20.80	6.07	3.47	1.73	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	31.09	6.15	0.16	0.47	1.10	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	25.46	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	11.87	2.00	9.74	0.27	0.13	0.53	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	25.01	20.01	1.43	4.29	1.43	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	16.93	1.39	5.10	0.23	0.00	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	21.30	2.37	1.01	0.34	0.00	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	18.85	2.36	5.60	0.88	0.59	1.18	0.00
amygdala - adult, donor10196	10167-103B5	23.72	5.93	0.00	1.19	0.00	2.37	0.00
amygdala, adult, donor10252	10151-102I7	25.35	7.71	2.23	1.22	0.41	1.42	0.20
amygdala, newborn, donor10223	10360-105E9	29.37	4.84	4.84	0.97	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	52.71	12.73	7.89	2.04	1.02	1.02	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	37.73	7.94	1.10	1.54	1.32	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	74.82	33.74	5.01	3.01	4.01	0.00	0.67
aorta, adult, pool1	10052-101G7	16.67	5.88	1.57	0.78	0.39	0.98	0.39
appendix, adult	10189-103D9	32.60	8.15	2.72	0.39	0.39	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	27.86	5.50	0.69	0.34	0.34	0.69	0.00
artery, adult	10190-103E1	12.23	4.08	0.00	0.00	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	37.38	18.54	2.03	2.61	1.59	0.29	0.14
b cell line:RPMI1788	10427-106D4	38.66	8.18	8.03	1.04	1.34	0.74	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	21.64	9.43	3.05	2.22	0.00	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	66.78	9.43	2.98	1.39	0.79	0.00	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	12.89	4.02	0.00	0.33	0.33	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	9.51	10.07	1.12	1.12	0.00	1.68	0.00
bladder, adult, pool1	10011-101C2	14.12	3.15	0.98	0.11	0.22	0.11	0.00
blood, adult, pool1	10053-101G8	0.00	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	29.12	4.28	2.57	2.57	0.86	0.00	0.00
bone marrow, adult	10192-103E3	24.97	9.45	3.37	0.67	2.02	2.02	0.00
brain, adult, donor1	10084-102B3	21.53	5.13	2.05	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	17.26	5.79	3.12	1.78	0.33	0.33	0.00
brain, fetal, pool1	10085-102B4	72.13	5.34	0.00	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	12.88	0.66	0.33	0.33	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	41.07	12.73	4.37	2.00	0.87	0.50	0.00
breast, adult, donor1	10080-102A8	17.05	1.89	0.00	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	16.13	10.80	0.38	0.13	1.91	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	20.72	8.66	0.93	0.93	0.62	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.05	9.21	5.06	0.69	0.69	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.62	3.87	0.73	0.00	0.73	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	15.05	4.70	0.94	1.88	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	24.28	7.88	1.09	0.98	1.53	0.11	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	24.72	6.34	0.63	0.00	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	30.34	18.90	2.13	3.73	3.19	1.06	0.27
caudate nucleus - adult, donor10196	10177-103C6	11.51	4.61	5.76	0.00	3.45	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	27.44	7.20	1.84	0.84	0.67	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	25.98	9.17	3.06	1.53	0.76	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	40.29	6.96	4.39	2.93	1.10	1.46	0.37
cerebellum - adult, donor10196	10173-103C2	20.39	17.48	17.48	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	51.24	15.80	4.27	4.06	1.92	1.92	0.00
cerebellum, adult, pool1	10083-102B2	20.70	8.97	5.52	0.69	2.07	1.38	0.69
cerebellum, newborn, donor10223	10357-105E6	40.68	9.13	6.64	4.15	0.83	1.66	0.83
cerebral meninges, adult	10188-103D8	25.21	5.29	2.02	1.01	1.26	1.01	0.50
cerebrospinal fluid, donor2	10294-104G6	12.43	2.19	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	13.66	11.22	1.01	1.44	2.16	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	12.93	5.47	2.65	0.17	0.50	0.17	0.17
cervix, adult, pool1	10013-101C4	28.14	9.24	1.47	1.47	1.89	0.73	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	39.29	11.29	2.65	1.81	1.39	0.28	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	11.76	5.23	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	13.17	5.72	0.25	0.37	0.62	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	22.42	4.31	0.37	0.49	2.09	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	9.01	1.19	0.00	0.47	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	15.96	1.42	3.70	1.14	0.57	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	22.17	6.46	4.47	1.69	0.40	0.50	0.00
chorionic membrane cells, donor3	12240-129G8	8.24	4.95	3.85	0.55	0.00	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	12.12	0.00	0.00	2.02	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	24.40	8.26	1.54	0.77	0.58	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	34.00	11.62	2.96	0.84	3.38	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	10.53	4.88	0.51	0.00	1.28	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	14.03	3.39	0.24	0.24	0.24	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	12.83	3.66	1.22	0.20	1.02	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	22.97	7.95	1.47	0.88	1.18	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	84.18	42.48	8.08	5.73	6.26	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	21.72	9.14	1.60	0.69	1.60	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	31.75	3.99	1.74	1.39	1.04	0.52	0.00
colon carcinoma cell line:CACO-2	10513-107D9	39.90	18.85	1.83	1.83	1.10	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	27.75	35.73	5.70	2.28	1.90	0.00	0.00
colon, adult, donor1	10082-102B1	20.23	0.00	2.38	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	15.51	5.52	0.94	0.47	0.59	0.59	0.00
colon, fetal, donor1	10070-101I7	21.63	2.47	1.85	0.62	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	105.42	18.33	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	25.04	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	54.39	21.67	20.40	3.40	0.85	3.82	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	22.94	9.06	5.58	1.96	0.45	1.51	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	25.66	8.46	7.47	1.69	0.00	1.13	0.14
corpus callosum, adult, pool1	10042-101F6	29.30	11.28	4.09	1.77	1.99	0.88	0.11
cruciate ligament, donor2	10295-104G7	12.16	0.81	0.00	0.00	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	31.30	5.62	1.61	0.80	0.00	0.80	0.00
diencephalon, adult	10193-103E4	12.24	7.92	1.20	1.20	0.72	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	15.15	7.58	1.38	0.46	0.69	0.23	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	21.80	5.64	1.28	0.51	1.03	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.44	6.02	3.85	1.20	0.96	0.48	0.00
ductus deferens, adult	10196-103E7	29.90	3.99	0.00	0.50	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	33.13	7.20	2.88	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.99	7.36	2.94	1.47	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	21.72	11.15	3.55	0.74	0.99	0.41	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.00	14.88	12.44	2.44	0.44	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.20	5.02	0.86	0.57	0.43	0.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	26.51	6.78	0.00	3.08	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	24.52	6.36	1.21	0.91	0.91	0.61	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.10	9.26	0.93	1.85	0.62	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	31.52	2.63	2.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	19.11	4.36	0.00	0.67	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	22.47	13.23	3.44	1.63	0.91	0.54	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.38	1.13	0.32	0.00	0.00	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	34.46	8.56	5.78	1.22	0.44	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	52.46	8.69	2.31	1.43	1.43	0.00	0.33
epididymis, adult	10197-103E8	23.86	4.60	2.30	0.84	0.84	1.05	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	24.66	7.63	1.95	1.95	2.13	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	13.37	11.80	0.79	1.57	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	15.86	7.21	2.36	1.83	1.44	0.66	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	15.16	12.70	2.66	1.67	1.28	0.79	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	15.01	6.39	1.12	1.23	0.78	0.34	0.11
esophagus, adult, pool1	10015-101C6	11.15	2.23	1.38	0.00	0.53	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	41.33	4.76	1.25	0.38	0.38	0.38	0.13
eye - muscle inferior rectus, donor1	10272-104E2	2.41	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	2.10	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	4.46	0.00	0.00	1.49	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	24.08	5.73	1.15	2.29	0.00	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	23.32	2.91	0.00	0.00	7.29	0.00	0.00
eye, fetal, donor1	10054-101G9	25.17	6.61	2.54	1.27	0.51	1.27	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	31.03	15.52	2.44	2.05	0.51	0.77	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	21.13	9.26	0.95	0.95	1.42	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	34.71	9.85	3.28	2.25	0.94	0.66	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	23.42	5.40	0.60	0.90	0.60	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.76	13.26	3.11	1.46	1.74	0.64	0.27
gall bladder, adult	10198-103E9	19.80	4.10	1.69	0.24	0.72	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	46.71	9.66	1.61	1.61	2.15	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	39.59	9.34	3.36	1.49	0.00	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.46	1.27	1.48	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.18	4.26	0.58	0.19	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	26.56	12.46	0.16	1.15	1.64	0.49	0.00
gastric cancer cell line:GSS	10560-108A2	19.22	16.47	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	25.59	13.25	5.25	1.60	1.14	2.28	0.46
giant cell carcinoma cell line:LU65	10487-107B1	7.46	5.62	0.00	0.23	1.03	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	52.76	7.98	3.36	0.70	1.68	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.72	4.99	0.25	0.75	0.75	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	26.28	2.85	2.43	0.63	0.42	0.63	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	24.86	2.53	1.40	0.84	0.28	0.56	0.28
glioblastoma cell line:T98G	10485-107A8	14.13	5.08	1.21	0.66	1.10	0.33	0.00
glioma cell line:GI-1	10413-106B8	20.79	8.20	4.69	1.17	0.29	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	15.31	7.29	2.92	1.46	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	24.17	9.28	1.71	0.98	0.49	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	20.54	6.85	2.74	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	34.11	3.73	1.60	1.07	0.53	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	92.99	12.24	0.00	0.00	4.89	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	32.79	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	25.92	4.16	0.32	0.00	0.00	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	9.18	5.97	0.46	0.46	0.92	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	9.15	6.86	1.37	0.91	1.83	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	18.68	4.51	1.29	1.93	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	15.81	8.62	0.00	1.44	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	13.72	6.86	2.06	0.00	2.74	0.00	0.00
hIPS, biol_rep3	14382-156B8	19.86	6.62	2.21	2.21	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	23.27	4.60	4.88	2.30	0.00	0.86	0.00
heart - mitral valve, adult	10205-103F7	32.29	6.58	2.69	1.79	0.60	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	23.79	6.54	1.83	0.00	0.26	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	29.14	2.50	0.00	0.83	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	16.12	3.47	1.22	1.22	0.61	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	11.50	2.55	1.28	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	14.26	1.61	0.69	0.23	0.92	0.23	0.00
heart, fetal, pool1	10046-101G1	52.47	11.40	4.31	1.95	0.72	0.62	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	26.22	3.70	4.01	1.85	0.00	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	23.78	3.57	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	18.12	8.51	1.66	1.55	0.44	0.44	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.85	12.38	1.58	1.58	0.36	0.61	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	26.17	10.31	1.62	1.62	0.40	0.30	0.00
hepatoma cell line:Li-7	10484-107A7	14.90	3.89	0.67	0.56	0.00	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	13.47	9.85	1.91	1.61	1.91	0.20	0.10
hippocampus - adult, donor10196	10169-103B7	13.25	3.79	3.79	0.00	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	29.39	8.16	1.43	1.43	0.82	0.82	0.61
hippocampus, adult, donor10258	10374-105G5	18.92	1.49	3.98	0.00	0.50	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	21.50	3.52	2.47	1.06	0.35	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	25.63	3.66	1.22	3.05	3.66	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.58	6.87	0.79	1.57	1.77	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	22.60	5.33	0.51	0.51	1.52	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	41.73	5.64	1.13	0.56	0.00	0.56	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.53	7.49	0.77	0.52	1.81	0.77	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.14	9.11	3.80	0.00	1.14	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	57.81	10.51	4.09	1.17	2.34	1.75	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	58.81	12.06	5.82	1.51	2.59	1.08	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	63.81	14.18	3.75	1.25	1.25	0.83	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	49.49	13.50	4.26	3.32	2.37	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	44.36	11.89	2.89	0.96	1.13	0.80	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	61.94	15.49	5.39	1.35	2.02	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.80	3.76	1.25	0.16	1.10	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	22.11	3.93	0.49	0.98	1.47	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	25.31	3.49	3.49	1.75	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	50.59	9.35	1.53	0.57	1.53	1.34	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.48	6.54	2.62	0.87	2.18	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	45.98	8.00	2.00	1.00	1.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.36	5.46	7.91	0.94	1.70	0.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	41.38	6.82	8.18	0.91	0.45	2.27	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	32.26	4.70	5.64	0.94	0.63	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	36.09	7.35	6.37	2.29	0.33	2.94	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	36.29	9.00	5.81	1.74	1.45	2.32	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	43.04	7.17	4.48	0.90	2.09	2.09	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	16.63	4.25	1.11	0.74	0.92	0.18	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.11	4.28	1.14	0.86	0.86	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	15.52	11.02	3.27	2.45	2.04	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.21	7.39	3.52	0.35	1.76	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	36.43	6.33	2.22	1.58	0.32	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	31.47	9.68	1.21	0.91	1.51	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	51.71	10.86	3.10	0.00	1.03	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	36.53	6.64	6.64	2.66	1.33	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	33.86	6.16	3.33	1.28	0.26	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	37.32	9.71	6.39	1.53	1.02	1.02	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	58.31	11.36	5.30	2.27	1.51	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.63	7.39	4.03	1.68	1.68	2.02	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	14.97	7.00	0.24	0.72	0.97	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.95	5.35	1.78	1.34	3.12	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	14.63	8.78	0.98	0.98	2.44	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.29	7.33	3.06	0.61	1.83	0.31	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	81.33	9.76	13.01	3.25	0.00	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	34.42	8.60	3.97	1.32	1.32	1.99	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	37.76	10.40	4.93	1.64	1.09	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	44.51	8.32	5.07	1.09	0.00	1.09	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	40.57	12.10	5.69	1.78	0.71	1.42	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	4.77	7.16	1.19	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	52.27	11.10	7.45	2.44	0.95	2.03	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	29.09	8.08	3.50	2.16	0.54	0.81	0.00
immature langerhans cells, donor1	11904-125F5	17.43	8.23	3.63	1.45	0.97	0.48	0.24
immature langerhans cells, donor2	11905-125F6	44.36	6.34	3.17	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	37.19	10.32	3.60	2.18	2.08	0.57	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	4.88	3.25	0.33	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	24.73	6.81	2.20	1.50	0.70	0.20	0.10
kidney, fetal, pool1	10045-101F9	42.23	6.86	2.41	0.85	1.06	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	72.86	19.60	7.10	4.40	1.70	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.38	3.46	1.80	0.83	0.00	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	28.99	6.24	3.85	0.92	0.73	0.73	0.00
left atrium, adult, donor1	10079-102A7	13.62	10.35	2.72	0.00	0.00	1.09	0.00
left ventricle, adult, donor1	10078-102A6	10.62	1.52	1.01	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	27.63	9.30	0.55	0.00	1.09	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	10.06	4.67	0.72	0.72	0.00	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	13.04	3.26	2.17	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	15.78	3.40	2.19	1.46	0.00	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	50.19	2.09	4.18	4.18	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	42.62	12.51	2.60	1.42	1.53	0.35	0.24
liposarcoma cell line:KMLS-1	10782-110G8	27.34	5.78	3.59	1.87	0.16	0.62	0.00
liposarcoma cell line:SW 872	10726-110A6	19.98	13.40	3.17	1.83	1.10	0.12	0.12
liver, adult, pool1	10018-101C9	10.70	2.76	0.49	0.32	0.32	0.32	0.00
liver, fetal, pool1	10086-102B5	12.23	4.70	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.44	6.42	1.46	0.87	0.58	0.58	0.00
locus coeruleus, adult, donor10252	10165-103B3	26.21	6.09	2.77	1.11	1.11	0.74	0.00
locus coeruleus, adult, donor10258	10375-105G6	23.14	6.21	3.95	2.54	0.00	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	23.98	4.63	7.57	3.36	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	16.88	3.60	2.63	1.38	0.00	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	11.03	1.38	0.69	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.97	7.38	1.32	1.05	2.11	0.13	0.26
lung, adult, pool1	10019-101D1	15.12	2.36	1.65	0.35	0.59	0.12	0.00
lung, fetal, donor1	10068-101I5	79.34	12.27	9.42	2.57	1.14	2.85	0.00
lung, right lower lobe, adult, donor1	10075-102A3	18.33	5.50	5.04	0.92	0.46	1.37	0.46
lymph node, adult, donor1	10077-102A5	8.99	8.52	1.42	0.00	0.00	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	14.25	2.41	2.85	0.44	0.22	0.88	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.13	11.47	0.75	1.51	0.75	0.30	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	28.88	11.04	2.55	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	13.76	4.44	0.44	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	11.62	4.36	1.45	0.62	1.04	0.62	0.00
mature adipocyte, donor3	12233-129G1	8.06	6.16	0.95	0.71	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	10.00	7.37	4.47	1.32	0.79	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	20.97	6.19	0.00	0.00	0.95	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	2.26	1.13	1.13	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	29.79	7.72	4.41	1.10	0.55	0.74	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	17.47	7.62	2.54	0.95	0.32	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	19.19	2.56	12.37	2.13	0.43	1.71	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	22.95	6.24	3.04	1.86	0.84	0.51	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	28.23	8.49	2.12	2.12	1.27	0.21	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	9.63	1.93	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	30.87	2.15	3.95	2.15	1.44	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	14.28	2.60	8.44	0.65	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	29.10	6.81	3.41	1.55	0.46	0.77	0.00
medulla oblongata, adult, pool1	10038-101F2	23.84	11.59	2.94	1.71	1.22	0.49	0.08
medulla oblongata, newborn, donor10223	10361-105F1	29.86	2.78	6.60	2.08	0.35	1.74	0.35
medulloblastoma cell line:D283 Med	10838-111E1	54.47	17.27	1.33	0.89	3.76	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	13.57	2.20	0.98	1.10	0.24	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	19.41	10.64	2.16	1.58	0.72	0.00	0.29
melanoma cell line:G-361	10465-106H6	8.96	4.34	1.09	0.00	0.00	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	16.10	3.44	5.07	0.90	0.18	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	31.72	8.81	1.76	2.64	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	53.14	9.59	0.78	1.04	1.04	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	16.42	5.83	1.69	0.31	0.15	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	18.72	6.54	6.18	2.18	0.55	0.91	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.46	4.14	1.66	1.24	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.37	7.02	5.34	2.53	0.00	0.56	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.29	4.04	2.50	1.73	0.00	0.77	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	5.55	2.08	2.78	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.00	5.84	3.43	1.03	0.17	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.85	3.57	2.65	0.92	0.12	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.64	4.77	1.72	0.80	0.13	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.29	4.32	1.76	1.49	0.14	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.15	8.82	3.70	3.41	0.43	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	32.28	7.25	6.59	1.98	0.66	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.47	3.74	1.94	0.97	0.00	0.55	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	33.16	4.89	3.84	1.75	0.70	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	27.97	5.10	7.76	3.27	0.00	0.82	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	41.70	8.27	7.55	1.80	0.72	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.35	2.48	2.28	1.34	0.10	0.72	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	27.59	7.75	3.65	0.46	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	31.47	6.71	2.94	1.68	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	32.73	4.33	5.23	1.94	0.45	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.30	4.81	3.15	1.75	0.18	0.61	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	47.86	8.10	16.20	4.42	0.74	1.47	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	47.50	8.30	11.45	2.86	0.57	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	44.63	13.47	5.05	2.53	1.26	1.26	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.53	2.28	1.83	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.11	3.84	2.81	0.51	0.26	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.58	2.88	1.83	1.31	0.26	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	2.46	0.92	2.16	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	17.65	3.06	2.12	0.71	0.47	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.54	2.71	1.35	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.75	3.54	3.54	1.96	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.90	3.24	0.93	1.39	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	20.19	4.04	2.88	0.58	0.29	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.96	4.02	2.90	0.22	0.22	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.55	3.85	2.16	1.20	0.48	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	4.40	1.47	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.43	3.36	1.01	1.01	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	18.42	4.09	1.64	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.04	3.01	0.43	1.29	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.94	2.60	0.65	2.27	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	1.45	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	21.86	6.40	1.60	0.53	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	10.63	2.45	1.64	0.00	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	3.11	1.94	0.39	0.39	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	2.98	0.00	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.01	4.15	0.59	1.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	2.44	1.22	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	27.05	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	2.53	1.90	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.21	1.72	0.69	1.03	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	8.60	2.15	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	0.00	0.00	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.56	2.85	1.22	0.81	0.00	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	4.77	0.79	0.00	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	3.54	1.18	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.04	3.43	0.62	0.31	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	6.68	1.34	2.67	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	2.37	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	5.14	2.57	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.70	3.44	0.00	1.38	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	5.44	0.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	3.36	0.00	1.12	2.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	9.54	3.18	0.00	1.27	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.45	2.01	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.32	3.03	1.82	1.21	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	3.29	3.29	0.82	0.82	0.00	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.10	3.77	0.79	1.19	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	3.24	0.65	0.97	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	7.13	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	28.63	6.19	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	20.08	15.36	1.89	1.65	1.65	0.47	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	30.58	4.87	4.63	0.93	0.23	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	32.67	7.30	2.57	2.88	0.51	0.21	3.60
mesothelioma cell line:Mero-25	10850-111F4	18.84	8.40	1.13	1.13	0.68	0.23	0.23
mesothelioma cell line:Mero-41	10851-111F5	19.31	3.42	3.42	0.49	0.00	0.49	0.73
mesothelioma cell line:Mero-48a	10852-111F6	17.05	2.21	0.89	0.44	0.00	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	24.97	14.45	12.61	4.73	0.53	1.58	1.31
mesothelioma cell line:Mero-83	10854-111F8	26.55	4.09	3.92	0.85	0.51	0.51	0.17
mesothelioma cell line:Mero-84	10855-111F9	13.65	1.77	1.01	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	16.36	2.69	1.45	0.41	0.83	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	34.95	9.11	3.81	2.48	0.99	0.66	0.33
mesothelioma cell line:NCI-H226	10846-111E9	16.29	9.95	1.45	1.81	0.72	0.18	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	23.06	5.47	2.73	2.22	0.68	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	14.25	3.56	0.76	1.53	0.51	0.00	0.25
mesothelioma cell line:No36	10857-111G2	19.57	3.59	2.94	0.33	0.33	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	30.89	5.15	1.35	1.35	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	10.94	2.30	2.30	0.77	0.38	0.96	0.00
migratory langerhans cells, donor2	11902-125F3	10.26	2.32	3.30	0.85	0.37	0.73	0.00
migratory langerhans cells, donor3	11903-125F4	12.92	4.49	3.05	0.54	0.18	0.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.32	8.81	0.65	0.98	0.65	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.37	8.48	2.54	1.91	0.42	0.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	47.68	5.99	1.61	2.07	1.61	0.23	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	15.03	4.57	2.47	1.33	0.38	0.19	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	31.97	12.94	2.22	1.29	1.48	0.55	0.00
myeloma cell line:PCM6	10474-106I6	13.84	3.36	3.95	1.38	0.40	0.79	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	39.57	3.55	2.54	1.52	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.01	8.24	1.37	2.16	0.59	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.03	2.56	1.11	0.11	0.22	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	8.97	2.43	0.81	0.44	0.07	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	11.04	4.42	2.21	1.10	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	51.07	24.85	0.46	2.30	2.30	0.69	0.00
neuroblastoma cell line:NB-1	10539-107G8	79.70	9.92	2.25	1.31	0.37	1.31	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	14.34	6.12	0.63	1.90	0.84	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	63.92	22.73	1.68	1.86	2.80	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	41.04	5.93	1.90	0.47	1.19	1.19	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	46.88	6.81	0.79	0.95	1.58	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	49.71	8.86	1.41	1.01	0.81	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	27.34	5.09	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.56	6.92	1.06	1.86	0.27	0.53	0.00
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	35.68	12.85	6.43	2.71	3.04	1.01	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	19.21	5.60	4.00	0.80	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	26.93	4.81	0.96	2.24	0.64	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	27.59	7.09	5.78	2.36	0.26	1.58	0.53
nucleus accumbens, adult, pool1	10037-101F1	35.15	9.37	3.66	1.87	1.78	0.37	0.19
occipital cortex - adult, donor10196	10172-103C1	39.15	10.30	4.12	4.12	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.57	7.25	2.42	0.54	1.34	0.81	0.81
occipital cortex, newborn, donor10223	10355-105E4	33.85	4.37	1.82	1.82	0.36	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	33.06	5.25	1.57	1.31	1.05	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	102.55	16.73	4.72	2.57	1.29	1.72	0.00
occipital pole, adult, pool1	10036-101E9	23.65	5.76	2.21	1.02	0.95	0.24	0.00
olfactory region, adult	10195-103E6	21.40	4.78	2.10	0.76	0.57	0.38	0.00
optic nerve, donor1	10277-104E7	32.02	10.01	0.00	4.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	18.68	6.72	1.82	1.25	0.80	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.56	7.42	0.55	0.55	1.10	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.41	4.57	0.68	0.85	0.85	0.51	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	9.70	3.35	0.58	0.46	0.58	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	34.69	6.17	5.59	1.47	0.59	1.76	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	17.75	2.80	2.80	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	54.50	10.60	6.36	1.91	2.33	0.42	0.21
ovary, adult, pool1	10020-101D2	37.56	7.16	3.23	1.57	0.96	0.79	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	38.86	7.15	4.95	2.02	0.37	0.55	0.37
pancreas, adult, donor1	10049-101G4	13.17	3.76	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	11.74	3.35	0.00	0.56	0.84	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	20.95	6.13	2.04	1.19	0.85	0.17	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	52.66	6.62	8.94	2.81	1.16	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	26.91	8.69	2.47	1.92	1.10	0.46	0.00
parietal cortex, adult, donor10258	10373-105G4	16.15	3.67	2.94	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	19.75	7.52	3.76	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	23.09	5.42	2.28	1.14	0.29	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	30.40	8.64	3.08	0.97	0.88	0.35	0.00
parietal lobe, fetal, donor1	10072-101I9	114.44	21.34	4.85	1.94	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	28.79	5.98	5.23	1.12	0.75	0.00	0.37
parotid gland, adult	10199-103F1	9.25	4.32	0.00	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	17.72	6.98	1.07	0.00	0.54	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	24.73	5.76	1.30	0.37	2.05	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	17.63	8.74	1.17	0.58	1.17	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	31.61	5.16	1.29	0.65	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	55.08	8.29	7.11	1.78	1.78	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	33.23	9.41	3.76	1.88	0.00	2.51	1.25
pituitary gland - adult, donor10196	10180-103C9	78.92	7.08	15.18	4.05	2.02	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	136.03	18.24	18.76	4.69	1.04	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	106.41	10.21	20.43	2.55	0.00	5.11	1.70
placenta, adult, pool1	10021-101D3	16.13	3.12	1.94	0.43	0.22	0.32	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	26.49	9.80	3.18	0.40	1.19	0.13	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	33.93	6.23	4.82	1.87	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	24.53	11.10	1.81	2.15	1.03	0.26	0.17
postcentral gyrus, adult, pool1	10032-101E5	21.97	7.93	3.05	0.96	1.92	0.61	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	83.66	25.10	0.00	0.00	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	16.52	5.51	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	34.08	9.76	2.33	1.46	1.75	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	47.73	11.43	2.00	1.09	0.36	0.36	0.36
prostate, adult, pool1	10022-101D4	24.12	6.89	1.27	0.82	0.45	0.18	0.18
putamen, adult, donor10196	10176-103C5	25.02	3.78	1.89	1.42	0.00	0.00	0.24
putamen, adult, donor10252	10152-102I8	15.69	1.96	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	17.48	3.28	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	19.09	3.87	2.66	0.72	0.48	0.24	0.72
putamen, newborn, donor10223	10365-105F5	16.49	4.50	8.25	2.25	0.00	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	30.55	11.06	2.91	1.45	0.87	0.00	0.00
rectum, fetal, donor1	10067-101I4	45.90	5.56	11.13	1.39	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	19.08	8.06	0.64	1.06	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.05	6.21	1.24	0.83	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	34.99	10.64	3.48	0.89	1.59	0.40	0.20
retinoblastoma cell line:Y79	10475-106I7	45.21	15.33	3.12	0.78	3.64	0.26	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.19	19.92	3.32	2.34	1.60	0.25	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	19.97	19.40	1.41	1.69	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	22.74	3.79	1.52	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	18.45	5.99	4.37	1.13	0.00	0.97	0.00
salivary acinar cells, donor2	11772-123I8	17.49	6.75	4.27	0.83	0.69	1.38	0.00
salivary acinar cells, donor3	11773-123I9	17.88	2.65	5.30	0.66	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	16.59	5.72	1.72	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	28.41	27.82	6.91	4.13	3.29	0.93	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	30.21	26.68	7.76	4.11	1.76	1.18	0.35
seminal vesicle, adult	10201-103F3	33.33	6.88	0.00	0.00	0.53	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.16	4.62	1.70	0.24	0.49	0.49	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.07	1.51	2.77	1.01	0.00	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	1.00	0.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.10	1.75	0.27	0.00	0.00	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	6.96	5.08	0.88	0.44	0.55	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	10.19	1.68	0.00	0.39	0.26	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	9.22	4.97	0.00	0.00	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	22.19	6.00	2.16	0.72	0.84	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	17.09	9.05	1.01	1.01	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	43.55	11.36	5.05	0.63	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.03	9.01	1.33	2.00	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	43.18	10.72	6.93	0.95	1.58	0.95	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	31.61	12.91	0.39	1.16	1.35	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	15.00	9.23	1.15	0.49	0.82	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	50.99	9.17	0.97	0.80	2.73	0.16	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	22.88	13.95	5.01	3.05	1.53	1.74	0.00
small intestine, adult, pool1	10024-101D6	21.74	6.81	2.27	1.31	0.72	0.48	0.12
small intestine, fetal, donor1	10064-101I1	18.92	8.11	1.47	0.74	0.98	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	11.80	3.08	3.08	0.00	2.56	2.56	0.00
smooth muscle, adult, pool1	10048-101G3	12.92	4.91	1.55	0.78	0.78	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	9.38	4.56	0.80	0.27	1.07	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	17.21	5.74	1.38	0.92	1.61	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	29.96	7.49	2.76	1.97	0.79	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	25.60	4.15	5.53	3.46	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	46.96	8.54	1.83	0.61	0.61	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	21.58	1.84	5.05	0.46	0.46	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.07	4.03	1.34	0.60	0.15	0.30	0.30
spleen, adult, pool1	10025-101D7	22.14	4.96	1.43	0.55	0.22	0.11	0.11
spleen, fetal, pool1	10044-101F8	30.83	6.12	1.27	1.11	0.56	0.40	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	19.98	4.87	4.45	0.41	0.31	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	20.70	5.89	1.52	0.19	0.76	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.86	5.94	0.70	0.70	0.70	0.00	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	33.23	7.43	4.30	0.00	0.78	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.04	44.24	7.99	5.85	5.07	0.79	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	25.42	0.85	2.12	0.85	0.00	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	25.81	25.81	5.08	5.08	2.12	0.42	0.42
stomach, fetal, donor1	10062-101H8	12.82	3.20	2.14	1.07	3.20	1.07	0.00
submaxillary gland, adult	10202-103F4	29.62	5.70	1.14	1.14	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.85	8.93	1.87	0.62	1.45	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	20.69	6.72	4.66	1.55	1.55	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	25.44	2.12	2.12	0.71	0.00	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	19.49	16.05	2.75	2.29	1.83	1.15	0.00
temporal lobe, adult, pool1	10031-101E4	24.33	5.00	2.29	0.76	0.68	0.59	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	72.65	14.25	8.55	3.56	0.71	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	65.49	6.59	5.27	3.96	0.88	1.32	1.32
tenocyte, donor1	11763-123H8	15.01	3.84	3.84	0.70	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	18.69	2.67	1.91	0.38	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	13.34	2.59	0.74	0.74	0.37	1.48	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	14.11	6.46	0.00	1.36	1.53	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	47.94	9.25	0.31	1.23	1.23	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	30.84	7.75	1.39	0.62	2.79	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.26	5.84	0.38	0.38	1.02	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	17.40	4.54	0.00	0.00	2.65	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.98	6.54	2.18	0.65	2.62	0.33	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	5.86	5.21	0.33	0.33	0.65	0.00	0.00
testis, adult, pool1	10026-101D8	20.62	13.85	3.44	6.87	0.75	0.75	0.21
testis, adult, pool2	10096-102C6	37.44	28.42	4.51	9.47	3.61	2.71	0.90
thalamus - adult, donor10196	10168-103B6	15.46	9.94	2.21	2.21	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	23.91	7.35	1.72	1.25	1.41	0.47	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	23.09	10.78	1.54	4.62	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.82	7.91	2.64	0.66	0.99	0.82	0.16
thalamus, newborn, donor10223	10366-105F6	17.26	5.75	6.33	1.15	0.00	0.58	0.00
throat, adult	10209-103G2	26.71	5.99	1.50	0.75	1.75	0.75	0.00
throat, fetal, donor1	10061-101H7	33.21	7.62	3.66	0.61	0.91	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	24.44	16.89	2.38	0.99	4.37	0.60	0.40
thymus, adult, pool1	10027-101D9	50.50	5.37	0.80	0.70	2.49	0.30	0.00
thymus, fetal, pool1	10043-101F7	74.29	9.25	1.25	1.45	1.35	0.21	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	34.97	16.09	3.46	2.66	1.20	0.66	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	40.79	20.39	4.75	1.54	3.07	0.28	0.14
thyroid, adult, pool1	10028-101E1	25.47	4.20	0.84	0.19	0.28	0.00	0.09
thyroid, fetal, donor1	10060-101H6	35.59	7.12	1.58	0.79	0.26	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	3.08	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	13.49	5.12	2.56	0.23	0.70	0.93	0.23
tongue, fetal, donor1	10059-101H5	18.92	5.91	0.79	0.79	0.39	0.79	0.00
tonsil, adult, pool1	10047-101G2	22.84	5.71	1.70	0.70	0.90	0.10	0.00
trachea, adult, pool1	10029-101E2	19.39	3.03	5.48	0.90	0.41	1.06	0.16
trachea, fetal, donor1	10058-101H4	30.01	3.85	3.46	0.77	0.77	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	35.78	3.90	1.06	1.06	0.35	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	40.63	6.69	3.24	1.93	0.71	0.30	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	36.19	25.85	1.88	2.04	3.45	0.47	0.31
tridermal teratoma cell line:HGRT	10694-109G1	22.83	1.90	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.00	3.72	1.61	0.42	0.25	0.17	0.08
umbilical cord, fetal, donor1	10057-101H3	18.78	4.17	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	34.13	13.65	3.41	2.39	1.54	0.68	0.00
uterus, fetal, donor1	10055-101H1	45.56	9.21	3.58	1.54	2.05	2.05	0.51
vagina, adult	10204-103F6	15.51	6.46	0.00	0.65	0.00	0.00	0.00
vein, adult	10191-103E2	22.80	4.82	0.88	0.88	1.10	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.08	2.40	2.40	0.80	0.27	0.00	0.00